Do high-grade breast cancers include both highly sensitive and highly resistant subsets to cytotoxic chemotherapy?
High-grade breast cancers include both highly sensitive and highly resistant subsets to cytotoxic chemotherapy. Three factors can help discriminate between these subsets. HR-negative and HER2-positive can be predictive of high chemosensitivity. Advanced primary tumor stage can be predictive of high chemoresistance.
For the first time, we demonstrated that CA-125 helps the risk stratification of patients with COPD.